期刊文献+

重组人TNF-α在大肠杆菌表达、纯化及生物学活性鉴定 被引量:1

Expression and purification of recombinant human tumor necrosis Factor α in Escherichia coli
原文传递
导出
摘要 [目的]获得人TNF-α蛋白,并鉴定其生物学活性。[方法]通过对人源TNF-α序列进行密码子优化构建了p Cold-TNFα原核表达载体,完成了TNF-α重组蛋白的表达,建立了两步分离纯化方案,并利用Western Blot和细胞刺激实验检测了重组人TNF-α蛋白抗原性和生物学活性。[结果]利用大肠杆菌成功表达重组人TNF-α蛋白,经酶切纯化后的人TNF-α蛋白不含标签序列,纯度达95%,收率约70%,并具有良好的生物学活性。[结论]获得具有生物学活性的人TNF-α蛋白,为进一步的中和抗体研究奠定了基础。 [Objective]To obtain the protein human TNF-α and analyze biological activity of this protein. [Methods] The p Cold-TNFα prokaryotic expression vector was constructed by codon optimization of human TNF-α sequence,and the expression of fusion protein TNF-α was completed. A two-step purification protocol was established. The experiments Western Blot and cell stimulation were performed on the recombinant protein TNF-α to detect the antigenicity and biological activity.[Results]The recombinant human TNF-α was successfully expressed in E. coli. The digested and purified protein human TNF-α without the tag sequence had a purity of 95%,a yield of about 70%,a good biological activity. [Conclusion]The protein human TNF-α with biological activity was obtained,which laid the foundation for the further studies on neutralizing antibodies.
作者 邓学天 毛海洲 刘丹丹 于淼 于双营 张守涛 Xuetian Deng;Haizhou Mao;Dandan Liu;Miao Yu;Shuangying Yu;Shoutao Zhang(School of Life Science,Zhengzhou University,Zhengzhou 450001,China;Department of Gastroenterology,No.155 Hispital of PLA,Kaifeng 475003,China)
出处 《生物技术》 CAS 2018年第4期335-340,312,共7页 Biotechnology
基金 国家"重大新药创制"科技重大专项("纤溶/抑制血小板聚集双功能溶栓药物研究" No.2012ZX09102301)
关键词 人肿瘤坏死因子Α 原核表达 亲和纯化 TNF - α prokaryotic expression affinity purification
  • 相关文献

参考文献6

二级参考文献28

  • 1何江,张杰.重组人TNF-α在大肠杆菌中的表达、纯化及生物学活性研究[J].中国优生与遗传杂志,2004,12(6):28-30. 被引量:3
  • 2Idriss HT, Naismith JH. TNF-α and the TNF reeaptor superfamily: structure-function relationship (s)[J]. Microsc Res Tech, 2000, 50 (3) : 184 -195.
  • 3Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games[ J]. Immunology, 2005, 115 ( 1 ) : 1 - 20.
  • 4Dohmen RJ. SUMO protein modification[ J ]. Biochim Biophys Acta, 2004, 1695(1 -3) : 113 -131.
  • 5Malakhov MP, Mattern MR, Malakhova OA, et al. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins[J]. J Struct Funct Genomics, 2004, 5( 1 -2) : 75 -86.
  • 6Butt TR, Edavettal SC, Hall JP, et al. SUMO fusion technology for difficult-to-express proteins[ J]. Protein Express Purif, 2005, 43 ( 1 ) : 1-9.
  • 7Idriss HT,Naismith JH. TNF alpha and the TNF receptor super- family : structure-function relationship (s) [ J ]. Microsc Res Tech, 2000,50 ( 3 ) : 184.
  • 8Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors [ J ]. Gastroenterology, 2000, 119 (4) :1148.
  • 9Kontoyiannis D, Pasparakis M, Pizarro TT, et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements : implications for joint and gut-associated immunopatholo- gies [ J ]. Immunity, 1999,10 ( 3 ) :387.
  • 10Decker T, Lohmann-Matthes ML, Gifford GE. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages [ J ]. J lmmunol, 1987,138 ( 3 ) :957.

共引文献13

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部